Clinical Trial: An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease.

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease (Seascape).

Brief Summary: This study will document the safety and efficacy of pasireotide s.c. in patients with Cushing's disease.